FIGURE 6.
Administration of MMNPmiR199a improves left ventricular remodeling and promote cardiac function recovery. (a) Representative Masson's trichrome–stained infarcted hearts two weeks after treatment (blue, scar tissue; red, viable myocardium). The fibrosis area (b) and scar size (c) of the left ventricular (LV) wall one weeks after treatment. (d) Representative M‐mode images 2 weeks after treatment. (e) Left ventricular ejection fraction (LVEF). (f) Hemodynamic analyses of LV end diastolic pressure (LVEDP). Data represent means ± SD. n = 8. **p < .01, ***p < .001